Insurance companies would have to provide coverage of routine costs and services for individuals participating in approved cancer clinical trials under a bill introduced in the House June 12 by Rep. Deborah Pryce (R-Ohio).
www.fdanews.com/newsletter/article?articleId=95175&issueId=10373